Lilian Torregrosa
Overview
Explore the profile of Lilian Torregrosa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ballesteros-Ramirez R, Pinilla P, Sanchez J, Torregrosa L, Aschner P, Uruena C, et al.
BMC Complement Med Ther
. 2023 Sep;
23(1):309.
PMID: 37670337
Background: Chemotherapy in breast cancer is effective but can generate significant toxicity and lead to tumor resistance. Joint treatment with standardized plant extracts can be an alternative to improve the...
2.
Dominguez L, Torregrosa L, Cuevas L, Pena L, Sanchez S, Pedraza M, et al.
Biomedica
. 2023 Jul;
43(2):252-260.
PMID: 37433160
Introduction: Workplace bullying and sexual harassment are concerns among general surgery residents in Colombia. Objetive: To explore the prevalence and impact of workplace bullying and sexual harassment incidents among general...
3.
Torregrosa L, Guevara O, Perez-Rivera C, Lozada-Martinez I, Saavedra C, Pedraza M, et al.
SAGE Open Med
. 2023 Mar;
11:20503121231162339.
PMID: 36993780
Objective: To evaluate and validate the medically necessary and time sensitive score by testing the variables, in order to create a surgical preoperative score for procedure prioritization in COVID-19 pandemic...
4.
Reyes A, Torregrosa L, Lozada-Martinez I, Cabrera-Vargas L, Nunez-Ordonez N, Martinez Ibata T
Am J Surg
. 2023 Jan;
225(5):937-938.
PMID: 36646599
No abstract available.
5.
Uruena C, Lasso P, Bernal-Estevez D, Rubio D, Salazar A, Olaya M, et al.
Sci Rep
. 2022 May;
12(1):7981.
PMID: 35562400
Neoadjuvant chemotherapy (NAT) in breast cancer (BC) has been used to reduce tumor burden prior to surgery. However, the impact on prognosis depends on the establishment of Pathological Complete Response...
6.
Duran M, Ballesteros-Ramirez R, Tellez A, Torregrosa L, Olejua P, Galvis S, et al.
Evid Based Complement Alternat Med
. 2022 Mar;
2022:7943001.
PMID: 35251213
The polyphenol-enriched extract called P2Et derived from had antitumor and immunomodulatory activities reported in breast cancer, leukemia, and melanoma. The aim of this study was to evaluate the safety and...
7.
Torregrosa L, Ariza A, Villarreal L, Cabrera Vargas L
Am J Surg
. 2021 Oct;
223(5):1010-1012.
PMID: 34702490
No abstract available.
8.
Alvarado-Cabrero I, Doimi F, Ortega V, Oliveira Lima J, Torres R, Torregrosa L
Cancer Rep (Hoboken)
. 2021 May;
4(6):e1400.
PMID: 33939336
Background: The incidence of breast cancer (BC) in LMICs has increased by more than 20% within the last decade. In areas such as Latin America (LA), addressing BC at national...
9.
Uruena C, Sandoval T, Lasso P, Tawil M, Barreto A, Torregrosa L, et al.
Sci Rep
. 2020 Nov;
10(1):19639.
PMID: 33184339
The main cause of death by cancer is metastasis rather than local complications of primary tumors. Recent studies suggest that breast cancer stem cells (BCSCs), retains the ability to self-renew...
10.
Rueda E, Suarez E, Gempeler F, Torregrosa L, Caballero A, Bernal D, et al.
Biomedica
. 2020 Nov;
40(Supl. 2):180-187.
PMID: 33152202
The pandemic caused by COVID19 is associated with an increase in the number of cases of cardiorespiratory arrest, which has resulted in ethical concerns regarding the enforceability of cardiopulmonary resuscitation,...